Apex Lab - Mobile Results

Free

2.02for iPhone, iPad

Apex Laboratory, Inc.

Developer

May 16, 2018

Update Date

Medical

Category

App Store

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

Apex Lab - Mobile Results Screenshots

iPad

iPhone

About Apex Lab - Mobile Results

Apex Laboratory, Inc.’s Apex Mobile is a laboratory result application that sends results directly to the ordering healthcare provider’s phone and/or tablet. Apex Laboratory, Inc. of New York and South Florida offers their clients (Doctors, Nurse Practitioners, Home Health Agencies, Nurses) the ability to view their patient’s results and search patient history from virtually anywhere. Doctors will also have the option to receive critical result notifications.

Registered Apex Laboratory providers must have their Apex Online username and password to access Apex Mobile. If you are a registered Apex Laboratory provider but do not know you online user account information, please contact us at 631-753-3900 or Florida accounts may call 561-279-1852.

Please note that all data is sent securely using the latest in encryption technology and our application is HIPAA compliant.